1.1M XNAS Volume
XNAS 03 Apr, 2025 5:30 PM (EDT)
MeiraGTx Holdings plc Key Metrics
Default
All financials are in USD Million and price data in USD
VIEW MORE
Low Financial Strength
Expensive Valuation
Technically Neutral
Momentum Trap
These stocks are the ones with poor quality and also financials and technical ranging from bad to medium score. This indicates that investors should be highly watchful with these stocks.
View Similar
Embed DVM
Check Before You Buy
VIEW FULL CHECKLISTLow rank
5Positive14Negative
26.3% Pass in checklist
Check P/E Buy Sell Zone
This stock has negative PE
MeiraGTx Holdings plc Stock Price Analysis
Day Price Range | 6.1 (LTP) 5.96.2 LowHigh |
Week Price Range | 6.1 (LTP) 5.97.5 LowHigh |
Month Price Range | 6.1 (LTP) 5.88.8 LowHigh |
52 Week Price Range | 6.1 (LTP) 3.88.8 LowHigh |
MeiraGTx Holdings plc Live Price Chart
Switch to TradingView
Fetching data ...
Revenue forecast
Miss
MeiraGTx Holdings plc's Revenue was lower than average estimate 2 times in past 3 years
Consensus Recommendation
5 ANALYST Recommendations
STRONG BUY
The consensus recommendation from 5 analysts for MeiraGTx Holdings plc is STRONG BUY
Forecaster is a Premium Feature
You need to upgrade your subscription plan to access this feature
See what you get MeiraGTx Holdings plc Stock Analysis
MeiraGTx Holdings plc stock analysis with key metrics, changes, and trends.
MeiraGTx Holdings plc Metric | VALUE | CHANGE % | TREND | ANALYSIS | |
---|---|---|---|---|---|
Annual Revenue | $33.28 M | 137.42% | positive |
| |
Annual Net Profit | $147.79 M | 75.89% | negative |
| |
Price to Earning Ratio | -3.27 | - | negative |
| |
Stock Price | $6.13 | 10.85% | positive |
| |
Quarterly Revenue | $21.39 M | 948.53% | positive |
| |
Quarterly Net profit | $39.4 M | 294.9% | negative |
| |
Mutual Fund Holding | 8.87 % | -0.28% | negative |
| |
Promoter Share Holding | 8.91 % | 0.8% | positive |
| |
Institutional Holding | 74.13 % | 0% | neutral |
|
Loading data..
MeiraGTx Holdings plc - Company Profile
What does MeiraGTx Holdings plc do?
MeiraGTx Holdings PLC is a clinical-stage gene therapy company. It focuses on the eye, salivary gland, and central nervous system disorders. The company's pipeline products include AAV-CNGB3, AAV-CNGA3 and AAV-RPGR, and others. Geographically, it operates in the United States, the United Kingdom, and European Union.
MeiraGTx Holdings plc Board of directors
All Gross Remunerations are in USD